Hematology

HAS-BLED Score

Bleeding risk assessment in patients on anticoagulation therapy

Share with colleagues

Input Parameters

Hypertension (uncontrolled, >160 mmHg systolic)*

Abnormal renal function (dialysis, transplant, Cr >2.26 mg/dL)*

Abnormal liver function (cirrhosis or bilirubin >2x normal or AST/ALT/AP >3x normal)*

Stroke history*

Prior major bleeding or predisposition to bleeding*

Labile INR (unstable/high INRs, time in therapeutic range <60%)*

Age >65 years*

Medication usage predisposing to bleeding (antiplatelet agents, NSAIDs)*

Alcohol use (≥8 drinks/week)*

Clinical Note (Optional)

0/500 characters

Other evidence-based tools commonly used alongside this calculator

PESI Score

Pulmonary Embolism Severity Index for risk stratification

Wells Criteria for PE

Clinical probability assessment for pulmonary embolism

Antiphospholipid Syndrome (APS) Risk Assessment

Risk stratification and treatment guidance for Antiphospholipid Syndrome — based on antibody profile and clinical features

Corrected Reticulocyte Count

Adjusted reticulocyte count for anemia assessment